Investing
Q2 confirmed that the artificial intelligence (AI) boom is entering a new phase in the physical world. As the industry evolves, attention is being...
Hi, what are you looking for?
America has triumphed in each industrial revolution – whether steel, energy or manufacturing – and has the power to lead the AI revolution, too....
Q2 confirmed that the artificial intelligence (AI) boom is entering a new phase in the physical world. As the industry evolves, attention is being...
After soaring to all-time highs during the first quarter of 2025, how could gold follow up during Q2? By setting new price records, of...
MACON, Ga. — When the crush of inflation became too much to bear a year and a half ago, Rashad James and Justin Williams...
CAMP DAVID, Md. — President Biden’s debate prep went fine. In the sessions, the president still spoke haltingly. He sometimes confused facts and figures....
Several Democratic allies of the president fanned out on Sunday to defend keeping President Biden as their party’s nominee, even as some donors, commentators...
Stephen K. Bannon — the sometime adviser to presumptive Republican nominee Donald Trump and influential podcast host who will report on Monday to serve...
Publicly, President Biden’s allies have spent the past several days aggressively downplaying his missteps in Thursday’s debate by assailing the “bedwetting brigade” of nervous...
James Carville, the longtime Democratic strategist known as the “Ragin’ Cajun,” said in an interview published Saturday that he does not think President Biden...
CNN moderator Dana Bash wanted to know how Donald Trump would fight climate change — the existence of which Trump has repeatedly questioned over...
Rep. Eric Swalwell (Calif.) struck the biggest moment of his bid for the 2020 Democratic presidential nomination on June 27, 2019. He did it...
Former president Donald Trump’s campaign advisers are pushing to significantly simplify and streamline the official platform of the Republican Party, according to a memo...
Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused on the development of an innovative and scalable intravenous-infused psilocin...